Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Seong Keun Kim, Sun Wook Cho
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 263

Showing 1-25 of 263 citing articles:

B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity
Céline M. Laumont, Brad H. Nelson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 466-489
Open Access | Times Cited: 92
Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies
Mohamed El‐Tanani, Syed Arman Rabbani, Rasha Babiker, et al.
Cancer Letters (2024) Vol. 591, pp. 216894-216894
Open Access | Times Cited: 46
Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies
Behnam Najafiyan, Zahra Bokaii Hosseini, Samar Esmaelian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116207-116207
Open Access | Times Cited: 24
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Yang Liu, Zhou Fei, Heba Ali, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1354-1375
Open Access | Times Cited: 22
Synthesis and Bioapplication of Emerging Nanomaterials of Hafnium
David Skrodzki, Matthew Molinaro, Richard S. Brown, et al.
ACS Nano (2024) Vol. 18, Iss. 2, pp. 1289-1324
Closed Access | Times Cited: 19
Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer
Ashutosh Gupta, Kumar Nishchaya, Moumita Saha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105401-105401
Open Access | Times Cited: 19
iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction
Bicheng Ye, Jun Fan, Lei Xue, et al.
iMeta (2025)
Open Access | Times Cited: 9
Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites
Yun Teng, Chao Luo, Xiaolan Qiu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications
Peijie Wu, Jun Han, Yanju Gong, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 1990-1990
Open Access | Times Cited: 43
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment
Rongyang Li, Bing Huang, Hui Tian, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 24
Advances in mRNA-Based Cancer Vaccines
Ling Ni
Vaccines (2023) Vol. 11, Iss. 10, pp. 1599-1599
Open Access | Times Cited: 23
The tumor-intrinsic role of the m 6 A reader YTHDF2 in regulating immune evasion
Sai Jin Xiao, Shoubao Ma, Baofa Sun, et al.
Science Immunology (2024) Vol. 9, Iss. 95
Open Access | Times Cited: 13
Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance
Dexin Xu, Wenhai Wang, Duo Wang, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 388-406
Open Access | Times Cited: 12
Cisplatin in the era of PARP inhibitors and immunotherapy
Mingrui Duan, Shuguang Leng, Peng Mao
Pharmacology & Therapeutics (2024) Vol. 258, pp. 108642-108642
Closed Access | Times Cited: 12
Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy
Τaxiarchis Κonstantinos Νikolouzakis, Emmanuel Chrysos, Anca Oana Docea, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1995-1995
Open Access | Times Cited: 11
Advancements and challenges in brain cancer therapeutics
Fan Bai, Yueyang Deng, Long Li, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 10
GAS5 lncRNA: A biomarker and therapeutic target in breast cancer
Lakshmi Thangavelu, Ehssan Moglad, Gaurav Gupta, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155424-155424
Closed Access | Times Cited: 10
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Landscape of exosomes to modified exosomes: a state of the art in cancer therapy
Divya Mirgh, Swarup Sonar, Srestha Ghosh, et al.
RSC Advances (2024) Vol. 14, Iss. 42, pp. 30807-30829
Open Access | Times Cited: 9
Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 9
Targeted therapy, immunotherapy, and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma
Jingwen Zhang, Anthony M. Joshua, Yue Li, et al.
Cancer Letters (2024) Vol. 586, pp. 216633-216633
Open Access | Times Cited: 8
Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future Directions.
Varsha Godakhindi, Mubin Tarannum, Sudip Kumar Dam, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Open Access | Times Cited: 8
Molecular Basis of Cancer
Lalima Tiwari, Omar Kujan
(2024), pp. 415-428
Closed Access | Times Cited: 8
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top